Digital Pharma: Boehringer's bedtime stories
Published on 05/10/09 at 04:17pm
Dominic Tyer
Dominic Tyer
Boehringer Ingelheim has published an online book for European patients suffering from restless legs syndrome.
The educational resource, which is available at rlsbookofbedtimestories.com, was launched from the company's European head office and contains short case studies of patients Sue (UK), John (UK), Silvana (Italy) and Hans (Germany).
The short 25-page volume offers information on the symptoms of RLS, lifestyle advice for managing them when mild or intermittent and notes that approved and effective RLS treatments are available.
It also includes a forward from Olympic track and field competitor and restless legs syndrome (RLS) patient Zola Budd-Pieterse.
It's not Boehringer's first online patient information effort. The company runs a German patient site for RSL and earlier this year launched the rlsunderthecovers.com website.
Boehringer markets RLS treatment pramipexole in Europe under the brand names Mirapexin and Sifrol, and is currently seeking approval for a new, once-daily prolonged-release formulation.
Dominic Tyer is web editor for Pharmafocus and InPharm.com and the author of the Digital Pharma blog. He can be contacted via email, Twitter or LinkedIn.
- Login or register to post comments
- Printer-friendly version
Mission Statement
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma jobs, pharma events, and pharma service company listings.
Site content is produced by our editorial team for InPharm.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
